Alymphia

Alymphia (from the Greek α - "a", lat. lympha - "moisture, liquid; lymph" - pharmacological treatment of the intestinal mucosa with antimicrobial and drugs that affect microcirculation and the structure of the gastric mucosa. Alymphia is prescribed in combination with diet therapy and taking certain drugs that normalize the microbiome environment of the small intestine. This has an effect on the body as a whole, including metabolism, immunity and even mood. For example, scientists from the Swedish Karolinska University in a double-blind, placebo-controlled study proved that stress in cancer can be reduced after taking alymphia due to the normalization of the gastrointestinal microbiota.

**Alphimphia is not a weight loss treatment**, however, reducing obesity and regular weight loss helps increase sensitivity to leptin, the lipolytic hormone responsible for